Polysaccharides: A Carrier for Gene Therapy

Author:

Yang Jing1,Li Yalan2,Wang Rui23,Bai Haotian2

Affiliation:

1. College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China

2. College of Basic Medical Science, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China

3. Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, Heilongjiang, China

Abstract

Abstract: Recently, polysaccharides have been proved to be an interesting drug delivery system as gene carriers, and natural polysaccharides have attracted more attention in the field of biomaterials due to their unique non-toxicity, good biocompatibility, and biodegradability. Compared with other polysaccharides, chitosan and dextran have more extensive and profound applications and can directly or indirectly deliver therapeutic genes. Chinese medicinal polysaccharides often do not have cationic groups and cannot directly deliver therapeutic genes. They usually need certain chemical modifications. The operation process is difficult, but better therapeutic effects are achieved. In this paper, the classification of polysaccharides and the research progress in modified polysaccharides as novel gene carriers are reviewed to provide a reference for polysaccharides as novel gene carriers in gene therapy. Moreover, efficient transfection of DNA and RNA therapeutic genes requires the development of new efficient and low-toxic vectors as well as the optimization of existing delivery vectors. Therefore, the research on polysaccharide gene vector has a long way to go and has good prospects in scientific research and biomedicine.

Funder

National Natural Science Foundation of China

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science

Reference51 articles.

1. Zhang B.; Yu J.; Advances in research on cationic polymer gene carriers. Shandong Med 2019,59(29),85-88

2. Choudhury S.R.; Hudry E.; Maguire C.A.; Sena-Esteves M.; Breakefield X.O.; Grandi P.; Viral vectors for therapy of neurologic diseases. Neuropharmacology 2017,120,63-80

3. Shalaby K.; Aouida M.; El-Agnaf O.; Tissue-specific delivery of CRISPR therapeutics: Strategies and mechanisms of non-viral vectors. Int J Mol Sci 2020,21(19),7353

4. Shi X.; Yao C.; Lin X.; Shen L.; Feng Y.; Advances in the application and research of polysaccharide. Zhongguo Xin Yao Zazhi 2014,23(09),1057-1062

5. Liu J.; Niu Y.; Pharmaceutical 2008,8-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3